Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway. Chaiyawat P, Sungngam P, Teeyakasem P, Sirikaew N, Klangjorhor J, Settakorn J, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Srisomsap C, Svasti J, Pruksakorn D*. Int J Oncol. 2019 May;54(5):1704-1718.

01 May 2019
0
0

Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway. 

Chaiyawat P, Sungngam P, Teeyakasem P, Sirikaew N, Klangjorhor J, Settakorn J, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Srisomsap C, Svasti J, Pruksakorn D*. 

Int J Oncol. 2019 May;54(5):1704-1718.

Tags

Share this

Related Posts

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.
05 Aug 2022
0

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.

Aekrungrueangkit, C.; Wangngae, S.; Kamkaew, A.; Ardkhean, R.; Thongnest, S.; Boonsombat, J.; Ruchirawat, S.; Khotavivattana, T. Novel Psoralen Derivatives as Anti-breast Cancer Agents and Their Light-Activated Cytotoxicity Against HER2 Positive Breast Cancer Cells. Sci. Rep. 2022, 12, 13487.
View More

Recent Posts